Pixium Vision implants IRIS® II, first epi-retinal implant with 150 electrodesadmin2019-09-11T17:33:01+02:00February 24th, 2016|
Pixium Vision receives approval from German Regulatory Authority to implant 150 electrode IRIS® II in clinical trialadmin2019-09-11T17:33:01+02:00February 16th, 2016|
Pixium Vision announces positive preclinical safety and feasibility data for PRIMAadmin2019-09-11T17:33:02+02:00January 7th, 2016|
Pixium Vision files for CE Mark for IRIS®II, its first Vision Restoration Systemadmin2019-09-11T17:33:03+02:00December 21st, 2015|
Pixium Vision receives approval from French Regulatory Authority to implant Iris® II in clinical studyadmin2019-09-11T17:33:03+02:00December 14th, 2015|
Pixium Vision receives the 2016 Observeur du design Award for IRIS®, its first Vision Restoration Systemadmin2019-09-11T17:33:03+02:00December 11th, 2015|
Availability of working documents for the General Meetingadmin2019-09-11T17:33:04+02:00November 23rd, 2015|
Pixium Vision wins the 2015 Janus Healthcare prize from prestigious French Institute of Designadmin2019-09-11T17:33:05+02:00October 28th, 2015|
Pixium Vision implants additional patients in the European clinical trial of its epi-retinal system IRIS®admin2019-09-11T17:33:05+02:00October 21st, 2015|
Pixium Vision co-laureate of the 7th Universal Biotech Innovation Prizeadmin2019-09-11T17:33:06+02:00October 7th, 2015|
Pixium Vision to Attend Upcoming Investor Conferencesadmin2019-09-11T17:33:06+02:00October 6th, 2015|
